Cargando…

The Changing Therapeutic Landscape of Metastatic Renal Cancer

The practising clinician treating a patient with metastatic clear cell renal cell carcinoma (CCRCC) faces a difficult task of choosing the most appropriate therapeutic regimen in a rapidly developing field with recommendations derived from clinical trials. NCCN guidelines for kidney cancer initiated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angulo, Javier C., Shapiro, Oleg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770566/ https://www.ncbi.nlm.nih.gov/pubmed/31443471 http://dx.doi.org/10.3390/cancers11091227

Ejemplares similares

Metastatic Urothelial Cancer: a rapidly changing treatment landscape
por: Stecca, Carlos, et al.
Publicado: (2021)

The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
por: Studentova, Hana, et al.
Publicado: (2023)

Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape
por: Hall, Mary E, et al.
Publicado: (2020)

The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
por: Parker, Daniel C., et al.
Publicado: (2020)

Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor–Positive Breast Cancer
por: Lee, Eunice Yoojin, et al.
Publicado: (2023)

Therapeutic Sequencing in Metastatic Renal Cell Carcinoma
por: Maia, Manuel Caitano, et al.
Publicado: (2017)

The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
por: Renert-Yuval, Yael, et al.
Publicado: (2017)

Metastatic renal cell cancer
por: Rasmussen, Finn
Publicado: (2013)

The Evolving Treatment Landscape for Metastatic Differentiated Thyroid Cancer
por: Grande, Carolyn, et al.
Publicado: (2014)

Metastatic breast cancer: Endocrine therapy landscape reshaped
por: Salkeni, Mohamad Adham, et al.
Publicado: (2017)

The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
por: Chand, Saswati, et al.
Publicado: (2016)

The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
por: Tria, Simon Manuel, et al.
Publicado: (2023)

The Changing Landscape of Alopecia Areata: The Translational Landscape
por: Wang, Etienne C. E., et al.
Publicado: (2017)

Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities
por: Graves, Angela, et al.
Publicado: (2013)

Genomic landscape of metastatic colorectal cancer
por: Haan, Josien C., et al.
Publicado: (2014)

Current landscape of therapeutic EUS: Changing paradigms in gastroenterology practice
por: Vanella, Giuseppe, et al.
Publicado: (2022)

The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2019)

Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
por: Devlies, Wout, et al.
Publicado: (2020)

The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer
por: Fanelli, Giuseppe Nicolò, et al.
Publicado: (2020)

Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review
por: Meagher, Margaret F, et al.
Publicado: (2023)

The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer
por: Taieb, Julien, et al.
Publicado: (2019)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics
por: Bessa, Cláudia, et al.
Publicado: (2020)

The therapeutic landscape of tauopathies: challenges and prospects
por: Cummings, Jeffrey L., et al.
Publicado: (2023)

Advanced Bladder Cancer: Changing the Treatment Landscape
por: Bilim, Vladimir, et al.
Publicado: (2022)

Genomic Landscape of Vinflunine Response in Metastatic Urothelial Cancer
por: Bernardini, Alejandra, et al.
Publicado: (2022)

Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K., et al.
Publicado: (2022)

The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma
por: Scarisbrick, Julia J., et al.
Publicado: (2020)

The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer
por: Dion, Ludivine, et al.
Publicado: (2020)

Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
por: Tien, Feng-Ming, et al.
Publicado: (2023)

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
por: De Mattos-Arruda, Leticia, et al.
Publicado: (2019)

The ever-changing landscape in modern dentistry therapeutics – Enhancing the emptying quiver of the periodontist
por: Diakoumopoulou, Dimitra, et al.
Publicado: (2021)

The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy
por: van der Mijn, Johannes C., et al.
Publicado: (2022)

The Evolutionary Landscape of Treatment for BRAF(V600E) Mutant Metastatic Colorectal Cancer
por: Mauri, Gianluca, et al.
Publicado: (2021)

Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
por: San-Román-Gil, María, et al.
Publicado: (2023)

Current Management Options in Metastatic Renal Cell Cancer
por: Gangadaran, Sittu Govindasamy Dinakaran
Publicado: (2017)

Resistance to cancer immunotherapy in metastatic renal cell carcinoma
por: Moreira, Marco, et al.
Publicado: (2020)

Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways
por: Wang, Hao, et al.
Publicado: (2021)

Changing Landscape of Systemic Therapy in Biliary Tract Cancer
por: Woods, Edward, et al.
Publicado: (2022)

Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade
por: Larroquette, Mathieu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_29qbpjkfj4k48rrkduk871bnir